🇺🇸 FDA
Patent

US 10591468

Circulating antibodies against MAA adducts as biomarker for coronary artery disease

granted A61KA61K49/00A61P

Quick answer

US patent 10591468 (Circulating antibodies against MAA adducts as biomarker for coronary artery disease) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K49/00, A61P, A61P9/10